Zachary L. Venn

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2)”.

HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2)

International Journal of Molecular Sciences(2022)10.3390/ijms24010274

N/A

0DataRank · unranked

5 citations

Chengju Tian, Sean R. Bidasee, Zachary L. Venn, Evan A. Schroder, Nicholas Y. Palermo +5 more

Diastolic Dysfunction with Vascular Deficits in HIV-1-Infected Female Humanized Mice Treated with Antiretroviral Drugs

International Journal of Molecular Sciences(2025)10.3390/ijms26083801

N/A

0DataRank · unranked

2 citations

Prasanta K. Dash, Ramasamy Mahendran, Zachary L. Venn, Sean R. Bidasee, Chen Zhang +4 more

Elevated Methylglyoxal: An Elusive Risk Factor Responsible for Early-Onset Cardiovascular Diseases in People Living with HIV-1 Infection

Viruses(2025)10.3390/v17040547

N/A

0DataRank · unranked

1 citations

Zachary L. Venn, Fadhel A. Alomar, Ali Namvaran Abbas-Abad, Benson Edagwa, Santhi Gorantla +2 more